Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001322458 | SCV001513332 | uncertain significance | Early-onset Parkinson disease 20; Developmental and epileptic encephalopathy, 53 | 2021-08-30 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003135971 | SCV003818870 | uncertain significance | not provided | 2019-10-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004679076 | SCV005165942 | uncertain significance | Inborn genetic diseases | 2024-05-20 | criteria provided, single submitter | clinical testing | The c.718G>T (p.A240S) alteration is located in exon 5 (coding exon 5) of the SYNJ1 gene. This alteration results from a G to T substitution at nucleotide position 718, causing the alanine (A) at amino acid position 240 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |